Indication
Haemophilus parainfluenzae bronchitis
*Haemophilus parainfluenzae* bronchitis is a lower respiratory tract infection characterized by bacterial inflammation of the bronchial mucosa caused by *Haemophilus parainfluenzae*, a Gram-negative opportunistic coccobacillus. Read more about Haemophilus parainfluenzae bronchitis
97 drugs 57 manufacturers
Drugs that treat it
Common Haemophilus parainfluenzae bronchitis therapies.
CEFDINIR
CEFDINIR
CEFDINIR
CEFDINIR
CEFDINIR
CEFDINIR
LEVOFLOXACIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Haemophilus parainfluenzae* bronchitis is a lower respiratory tract infection characterized by bacterial inflammation of the bronchial mucosa caused by *Haemophilus parainfluenzae*, a Gram-negative opportunistic coccobacillus.
It most commonly manifests as an acute bronchitis or an acute bacterial exacerbation of chronic bronchitis in adults, particularly individuals with underlying chronic obstructive pulmonary disease, impaired mucociliary clearance, or compromised immune defenses.
Pathophysiologically, the organism colonizes the tracheobronchial epithelium, triggering neutrophil infiltration, mucosal edema, and hypersecretion of mucus.
Clinically, affected patients present with a persistent cough, increased volume or purulence of sputum, chest congestion, wheezing, and varying degrees of dyspnea.
- fda.gov
*Haemophilus parainfluenzae* bronchitis is a lower respiratory tract infection characterized by bacterial inflammation of the bronchial mucosa caused by *Haemophilus parainfluenzae*, a Gram-negative opportunistic coccobacillus It most commonly manifests as an acute bronchitis or an acute bacterial exacerbation of chronic bronchitis in adults, particularly individuals with underlying chronic obstructive pulmonary disease, impaired mucociliary clearance, or compromised immune defenses
- nih.gov
*Haemophilus parainfluenzae* bronchitis is a lower respiratory tract infection characterized by bacterial inflammation of the bronchial mucosa caused by *Haemophilus parainfluenzae*, a Gram-negative opportunistic coccobacillus It most commonly manifests as an acute bronchitis or an acute bacterial exacerbation of chronic bronchitis in adults, particularly individuals with underlying chronic obstructive pulmonary disease, impaired mucociliary clearance, or compromised immune defenses
- yalemedicine.org
*Haemophilus parainfluenzae* bronchitis is a lower respiratory tract infection characterized by bacterial inflammation of the bronchial mucosa caused by *Haemophilus parainfluenzae*, a Gram-negative opportunistic coccobacillus Clinically, affected patients present with a persistent cough, increased volume or purulence of sputum, chest congestion, wheezing, and varying degrees of dyspnea
- ersnet.org
It most commonly manifests as an acute bronchitis or an acute bacterial exacerbation of chronic bronchitis in adults, particularly individuals with underlying chronic obstructive pulmonary disease, impaired mucociliary clearance, or compromised immune defenses Pathophysiologically, the organism colonizes the tracheobronchial epithelium, triggering neutrophil infiltration, mucosal edema, and hypersecretion of mucus
- nih.gov
Pathophysiologically, the organism colonizes the tracheobronchial epithelium, triggering neutrophil infiltration, mucosal edema, and hypersecretion of mucus Clinically, affected patients present with a persistent cough, increased volume or purulence of sputum, chest congestion, wheezing, and varying degrees of dyspnea
- buffalo.edu
Pathophysiologically, the organism colonizes the tracheobronchial epithelium, triggering neutrophil infiltration, mucosal edema, and hypersecretion of mucus
- mayoclinic.org
Clinically, affected patients present with a persistent cough, increased volume or purulence of sputum, chest congestion, wheezing, and varying degrees of dyspnea
Personalize your experience
Follow Haemophilus parainfluenzae bronchitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.